Bone morphogenetic protein‐2 regulates proliferation of human mesenchymal stem cells

Human mesenchymal stem cells obtained from the iliac crest of a single donor were investigated for cell proliferation, cell cycle profile, gene expression, and ultrastructural changes using electron microscopy. The human mesenchymal stem cells significantly increased their cell number by day 2 after treatment with bone morphogenetic protein‐2 alone, or basic fibroblast growth factor alone or combinations of both proteins under serum‐free conditions (p < 0.01). The human mesenchymal stem cells showed marked expression of cell nuclear antigen, notably at day 1, and pituitary tumor transforming gene throughout the experiment, suggesting cell cycle progression by bone morphogenetic protein‐2 treatment. In addition, strong cellular nuclear bromodeoxyuridine incorporation was seen by immunocytochemistry. Fluorescence‐activated cell sorting also showed a similar pattern of cell cycle progression with bone morphogenetic protein‐2 treatment in serum‐free medium and 10% fetal bovine serum treatment. The bone morphogenetic protein‐2–treated human mesenchymal stem cells showed heterochromatin in the nucleus, suggesting cell differentiation, and well‐developed granular endoplasmic reticulum, indicative of protein production. Overall, the human mesenchymal stem cells successfully proliferated with appropriate cell cycle progression and the cell ultrastructural morphology suggested marked nuclear and granular endoplasmic reticulum induction by bone morphogenetic protein‐2 treatment in serum‐free medium. (WOUND REP REG 2003;11:354–360)

[1]  N. Shepherd,et al.  The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S + G2 + M phase fraction (flow cytometric analysis) and prognosis , 1991, Histopathology.

[2]  J. Rémy-Martin,et al.  Retroviral-mediated marker gene transfer in hematopoiesis-supportive marrow stromal cells. , 1998, Journal of Hematotherapy.

[3]  A. McMahon,et al.  Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation. , 2001, Development.

[4]  D J Prockop,et al.  Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Xuebin B. Yang,et al.  Adenoviral BMP-2 gene transfer in mesenchymal stem cells: in vitro and in vivo bone formation on biodegradable polymer scaffolds. , 2002, Biochemical and biophysical research communications.

[6]  G. W. Huntley,et al.  Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span. , 2002, The Journal of clinical investigation.

[7]  S. Ogawa,et al.  Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.

[8]  D J Prockop,et al.  Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Bruder,et al.  Growth kinetics, self‐renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation , 1997, Journal of cellular biochemistry.

[10]  D. Benayahu,et al.  Single‐Colony Derived Strains of Human Marrow Stromal Fibroblasts Form Bone After Transplantation In Vivo , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  E. Neilson,et al.  Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.

[12]  D. Marshak,et al.  Human mesenchymal stem cells respond to fibroblast growth factors. , 1997, Human cell.

[13]  M. Pittenger,et al.  Adult Human Mesenchymal Stem Cell Differentiation to the Osteogenic or Adipogenic Lineage Is Regulated by Mitogen-activated Protein Kinase* , 2000, The Journal of Biological Chemistry.

[14]  Darwin J. Prockop,et al.  Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta , 1999, Nature Medicine.

[15]  S. Melmed,et al.  Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division. , 2001, Molecular endocrinology.

[16]  D. Prockop,et al.  Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats--similarities to astrocyte grafts. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Luna,et al.  Cell cycle regulated expression and phosphorylation of hpttg proto-oncogene product , 2000, Oncogene.

[18]  A I Caplan,et al.  Stimulatory Effects of Basic Fibroblast Growth Factor and Bone Morphogenetic Protein‐2 on Osteogenic Differentiation of Rat Bone Marrow‐Derived Mesenchymal Stem Cells , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  S. Bruder,et al.  Osteogenic differentiation of purified, culture‐expanded human mesenchymal stem cells in vitro , 1997, Journal of cellular biochemistry.

[20]  P. Bianco,et al.  Marrow stromal stem cells. , 2000, The Journal of clinical investigation.

[21]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[22]  Fusca.  Product , 1972, The Veterinary record.